RecruitingNCT05778006
Multi-Center Registry for ME/CFS
Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)
Sponsor
Technical University of Munich
Enrollment
650 participants
Start Date
May 31, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The ME/CFS study (MECFS-R) aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for ME/CFS at any age in Germany, which can be used for future clinical trials.
Eligibility
Min Age: 0 Years
Inclusion Criteria2
- ME/CFS diagnosis (ICD-10 G93.3) based on internationally established criteria
- Informed consent by patients and/or guardian(s)
Exclusion Criteria2
- No ME/CFS (ICD-10 G93.3)
- No informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05778006
Related Trials
Patient-Centered Assessment of Symptoms and Outcomes
NCT039526241 location
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT048066201 location
OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)
NCT073522541 location
LIFT: Life Improvement Trial
NCT063667241 location
The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NCT062110621 location